Ascentage Pharma Group International (HKG:6855) completed the placing and issue of a total of 44 million shares at HK$68.60 apiece to raise net proceeds of HK$1.49 billion, a late July 25 Hong Kong bourse filing said.
Shares of the pharmaceutical company were up over 3% in Monday afternoon trading.
The firm placed 22 million shares to at least six investors and allotted and issued the same number of shares to Dajun Yang Dynasty Trust.
The company will use proceeds from the issue for commercialization efforts, worldwide clinical development, and infrastructure and working capital for global operations.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。